Skip to main content
Clinical Trials/NCT05975892
NCT05975892
Enrolling By Invitation
Phase 1

Transplantation of Bone Marrow Mesenchymal Stromal Cells for Bone Regeneration in Periodontal Disease

Instituto Venezolano de Investigaciones Cientificas1 site in 1 country30 target enrollmentAugust 30, 2018

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Chronic Periodontal Disease
Sponsor
Instituto Venezolano de Investigaciones Cientificas
Enrollment
30
Locations
1
Primary Endpoint
Change in clinical attachment level (CAL)
Status
Enrolling By Invitation
Last Updated
2 years ago

Overview

Brief Summary

The goal of this study is to evaluate the capacity of allogeneic bone marrow mesenchymal stromal cells (MSC) to induce bone regeneration in patients with periodontal disease. MSC cultured are loaded on a collagen scaffold, included into autologous platelet rich plasma clot and implanted in the bone defect.

Detailed Description

The clinical protocol is designed to evaluate the bone regeneration capacity of allogeneic MSCs for the treatment of patients with chronic or aggressive periodontal disease. Patients with either a 2- or 3-wall intrabony defects are included in this study. A bioengineering construct, constituted by allogeneic MSCs and a collagen scaffold, is incorporated into platelet rich plasma (PRP) clot, which is implanted at the bone defect site. Follow up of treated tooth are assessed by clinical evaluation, intraoral radiography and cone-beam CT.

Registry
clinicaltrials.gov
Start Date
August 30, 2018
End Date
August 30, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dylana Diaz Solano

Clinical Investigator

Instituto Venezolano de Investigaciones Cientificas

Eligibility Criteria

Inclusion Criteria

  • Medical healthy
  • Minimum age of 18 years old
  • Diagnosis of chronic or aggressive periodontitis
  • Vertical intrabony defects of three or two walls
  • PPD \>= 5 mm
  • Radiographic evidence of alveolar bone loss of at least 3 mm
  • Minimim 20 teeth presents in mouth.
  • Informed consent of the patient

Exclusion Criteria

  • Pregnancy or lactating
  • Receiving immunosuppressive drugs, anticoagulants, antibiotics or analgesic drugs
  • Diabetics

Outcomes

Primary Outcomes

Change in clinical attachment level (CAL)

Time Frame: Follow-up includes evaluation at 3, 6, 9 and 12 months post-transplantation

Expressed as the distance in millimeters from the cemento-enamel junction (CEJ) to the bottom of the probable gingival/periodontal pocket.

Change in bone density

Time Frame: Follow-up includes evaluation at 3, 6, 9 and 12 months post-transplantation

Changes in the density of the periodontal bone defect will be detected by Cone beam Tomography

Change in Tooth Mobility (TM)

Time Frame: Follow-up includes evaluation at 3, 6, 9 and 12 months post-transplantation

Changes from baseline in tooth mobility will be recorded.

Change in probing pocket depth (PPD)

Time Frame: Follow-up includes evaluation at 3, 6, 9 and 12 months post-transplantation

The distance from the gingival margin to the bottom of the gingival sulcus/pocket, is measured by means of periodontal probe.

Gingival recession (GR)

Time Frame: Follow-up includes evaluation at 3, 6, 9 and 12 months post-transplantation

Exposure of the tooth through apical migration of the gingiva will be recorded as the distance in millimeters from the CEJ to the gingival margin

Change in bone depth

Time Frame: Follow-up includes evaluation at 3, 6, 9 and 12 months post-transplantation

The vertical bone defects will be assessed by X-rays. The postoperative depth of the intrabony defect will be calculated from the distance between the cemento-enamel junction and the bone crest on the preoperative and postoperative radiographs at the same magnification.

Study Sites (1)

Loading locations...

Similar Trials